LAS VEGAS – Scleroderma patients should be screened every year for pulmonary hypertension even if they are recently diagnosed and have no respiratory symptoms.
Noninvasive tests can catch pulmonary problems early, and treatments are available to slow the progression of scleroderma. Dr. Dinesh Khanna, director of the University of Michigan’s Scleroderma Program in Ann Arbor, discussed how to perform scleroderma screening at a conference held by Global Academy for Medical Education. Global Academy for Medical Education and this news organization are owned by Frontline Medical Communications.